Tag Archive | "Genzyme"

Sanofi – Genzyme deal finally goes through

Tags: , , ,


French drugmaker Sanofi-Aventis has finally struck a deal to acquire U.S. biotech company Genzyme for $20.1 billion plus future payments based on the performance of Genzyme's experimental multiple sclerosis drug, Lemtrada. Read the full story

Genzyme completes sale of diagnostics business to Sekisui Chemical

Tags: ,


Genzyme Corporation today announced that it has completed the sale of its diagnostic products business to Sekisui Chemical Co., Ltd. for $265 million in cash. Read the full story

Genzyme will allow Sanofi to conduct due dilligence

Tags: , ,


Genzyme Corp. announced today that ongoing discussions with Sanofi-Aventis have progressed to the point where Genzyme’s board has authorized the company to enter into a confidentiality agreement with Sanofi-Aventis in order to allow Sanofi to conduct due diligence. Read the full story

Sanofi once again extends tender off for Genzyme

Tags: , ,


Sanofi once again has had to extend its $18.5 billion bid for Genzyme. "Sanofi -Aventis and Genzyme are engaged in discussions regarding the structure of a contingent value right involving Lemtrada (alemtuzumab MS) as an element of any potential transaction," the company says in a statement. Read the full story

Will Sanofi, Genzyme chiefs talk deal at JPMorgan?

Tags: , ,


Could it be time to talk in the long-running saga of Sanofi-Aventis' $18.5 billion bid for Genzyme? Read the full story

Laboratory Corporation of America Holdings successfully completes acquisition of Genzyme Genetics for $925 Million

Tags: ,


Laboratory Corporation of America® Holdings has announced the successful completion of its acquisition of Genzyme Genetics, a business unit of Genzyme Corp., in an all cash transaction valued at $925 million. Net of expected income tax benefits, less acquisition-related expenses, the acquisition has a net cash cost to LabCorp of approximately $795 million. Read the full story

Genzyme mulls new Sanofi deal structure

Tags: , ,


Genzyme is exploring a new deal structure that could break an acquisition deadlock with Sanofi-Aventis, the Wall Street Journal reports. Read the full story

GSK: Not interested in Genzyme deal

Tags: , ,


Despite runours, GSK's Patrick Vallance, senior vice president of medicines discovery and development, says his company isn't considering a bid for Genzyme Read the full story

Genzyme restructuring moves forward with sale of diagnostic ops

Tags: , , ,


It's two down and one to go for Genzyme's ($GENZ) restructuring crew. Read the full story

Sources: Genzyme floats $82 bid by Takeda

Tags: , , ,


Anxious to stir up a bidding war, Genzyme has reportedly initiated a discussion with Japan's Takeda around an $82-per-share target offer, according to a number of press reports. Read the full story